Key result
Antidepressant use was associated with a reduced risk of fatal or nonfatal myocardial infarction (OR 0.49; 95% CI 0.38-0.64), with no significant sex-specific interaction.
Why the study?
Antidepressants are thought to affect cardiovascular disease risk, but the nature of the association and whether it is sex-specific remain unclear.
Does antidepressant use reduce the risk of fatal or nonfatal myocardial infarction in a general population?
Cohort (n=31,765)
Does antidepressant use reduce the risk of fatal or nonfatal myocardial infarction in a general population?
Odds Ratio: 0.49 (95% CI 0.38–0.64)
In a large Norwegian population cohort, antidepressant use was associated with a significantly reduced risk of subsequent fatal or nonfatal myocardial infarction in both men and women.
Antidepressant-MI association should not change practice; leaves open confounding and requires RCTs to test causality.
OBJECTIVE: Antidepressants are thought to affect the risk of cardiovascular disease, although the nature of the association is unclear. Men and women have unique cardiovascular risk factors, and sex differences in depression as well as the efficacy of antidepressants are important to consider. We examined whether antidepressant use was associated with risk of having a myocardial infarction (MI) and whether this association was sex-specific. METHODS: Data from The Trøndelag Health Study were used, gathered from a population in Norway ( N = 31,765), collected from 1995 to 2008. These data were combined with the Norwegian Cause of Death Registry and the Norwegian Prescription Database. We performed logistic regression models to examine the association of antidepressant use on risk of having a fatal or nonfatal MI, adjusting for depression, anxiety, diabetes, systolic blood pressure, cholesterol, waist-hip ratio, smoking, age, and sex. Results are presented as odds ratios (ORs) and 95% confidence intervals in parentheses. RESULTS: The results indicated that antidepressant use was associated with a reduced risk of having MI at a later date (OR = 0.49 [0.38-0.64]). Although this association was somewhat stronger for women (OR = 0.46 [0.31-0.68]) compared with men (OR = 0.53 [0.37-0.75]), analysis did not identify a sex-specific association of antidepressant use on MI. Follow-up analyses on different subtypes of antidepressants showed that both selective serotonin reuptake inhibitor and tricyclic antidepressant were associated with a reduced risk of MI. CONCLUSIONS: In this population study, the use of antidepressants was associated with a reduced risk of MI. This association was stronger for women, although we detected no interaction between sex and antidepressant use in terms of reduced risk of MI. Although limitations apply regarding causality, especially concerning a dose-response relationship, the results suggest that antidepressant use might reduce the risk of MI among both men and women.
No takes yet. Share an insight, caveat, or question.
Karlsen et al. (2022) reported a cohort. Antidepressant use vs. Non-use of antidepressants was evaluated on fatal or nonfatal MI (OR 0.49, 95% CI 0.38-0.64). Antidepressant use was associated with a reduced risk of fatal or nonfatal myocardial infarction (OR 0.49; 95% CI 0.38-0.64), with no significant sex-specific interaction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: